Our technologies

Please click on each tab to get more information:

Technology began when human beings started using sticks and stones as primitive tools to dig in the dirt or as weapons. They later figured out that the shape of sticks and stones could be altered to create a sharp blade and to allow for better handling. That was the beginning of science. At the end of the 19th century and first half of the 20th century, human beings devoted themselves to developing the classical natural sciences: biology, physics and chemistry. The milestones achieved in science allowed a large number of technologies to be created in different fields of science during the second half of the 20th century. This is why the 20th century will go down in history as the technology century. There is no doubt that the most impressive achievement of this century is in biotechnology, which gave rise to a substantial increase in harvests, the green revolution and the mass production of household items.

In the future, industrial biotechnology must become the main contributor to sustainable technologies, drawing us toward organic chemistry, the reuse of technology and the bio-economy. Industrial biotechnology has also allowed us to use urban waste and to create agro-industrial and food processes that can now transform these wastes into a variety of chemical compounds, such as refined and bulk chemicals, solvents, pharmaceuticals, bio-plastics, vitamins, pigments, food additives, biological pesticides, bio-fuels and other valuable compounds.

The main component of modern biotechnology is based on microorganism technologies, which account for approximately 80% of all biotechnology. Microorganisms, with their highly diverse metabolic activities, represent an almost unlimited source of biological activity with relevance for industrial applications.


GOMBORI applies the most modern technologies to produce a series of physiologically active biological compounds.

Several aspects make GOMBORI unique as a company that manufactures bio-active preparations for use in medicine, agriculture and industry.

The basis of microbial technology is the existence of a broad collection of microorganisms. GOMBORI has a unique collection of microorganisms, which include the various taxonomic groups – bacteria, fungi, yeasts and actinobacteria – with a total of more than 11,000 individual strains.

This number of strains has been collected over more than 35 years, from 18 climatic zones with different soils, from the southern and northern Caucasus, the Middle East, and the Mediterranean countries, as well as strains received from other collections that exist in the former Soviet republics, Europe and the United States. To get a rough idea about what the work of the scientists means in terms of isolating and purifying each strain, it is worth noting that the study of each of strain entails an average of more than 700 hours of work.

The physiological characterization of each strain, once isolated and purified, requires researchers to devote an addition 500 hours of personal work. Only then is the product ready for biochemistry research, allowing scientists to touch on aspects of biosynthesis, degradation of capacities, and transformational potential. 1200 hours per strain x 11,000 strains = more than 1500 person-years of scientific work.

The study of the collection’s strains revealed the existence of more than 800 extremophiles (organisms that grow under extreme conditions of high and low temperature, high and low acidity, high concentration of salts, etc.) These strains are of great interest from an industrial perspective, since they operate under conditions where normal mesophilic strains (which includes most of the industry currently available) do not exhibit activity. Especially interesting are the enzymes of these extremophile microorganisms, since they have greater stability under real-world industrial conditions and which therefore are important for such applications. Thus, according to its current and future plans, GOMBORI will focus mainly on the stability of bio-molecules produced by extremophiles.

Microbial enzymes and secondary metabolites received from microbial synthesis are used in modern technologies to produce bioethanol from starch, by means of thermostable alpha amylases. The next step in industrial enzymology would be to develop the conversion of agricultural waste into cellulose bioethanol and unicellular protein for animal and poultry feed. There is no doubt that the development of this type of technology will lead to a significant increase in the demand for cellulose-degrading enzymes, for which reason production of celulases and their use in associated technologies will increase. Since the potential uses of conventional mesophile enzymes has nearly reached its logical conclusion, the use of extremophile microorganisms, enzymes and other stable molecules must become the main basis for the development of microbial technologies.


The know-how in Gombori products involves the use of a number of bioactive preparations and activators from INAGROSA (one of Gombori´s shareholders). These preparations are used to prolong the action of enzymes and to regulate internal metabolic processes, focused on the synthesis of secondary metabolites (low molecular weight compounds).

As it has been demonstrated in practice, the use of INAGROSA preparations increases crop harvests, improves crop quality, and even increases the phytoremediation potential of plants.

GOMBORI produce biosurfactants and stable enzymes jointly with the INAGROSA bio-preparations, possessing a technology that offers great advantages over enzymatic technologies based on conventional mesophilic strains. First off, while there is currently less demand for the use of stable enzymes that continue their activity over a longer period of time, the fact that they can be used for a longer period of time makes the product more competitive. These technologies are far more profitable, especially in the case of waste from cellulose and xylan. The amount of carbon fixed annually by photosynthesis, according to different estimates, is around 180 thousand million tons. The production of glucose, bioethanol, unicellular proteins, and other valuable products from cellulose-containing substrates under extreme conditions will be the technology of the future.

Technology background

Our Strengths

Evidently we have Standard or “Catalogue” products. You can check them at OUR PRODUCTS section.

Nevertheless, what we DO BEST is to MANUFACTURE THE BIOPREPARATION THAT YOU NEED for your specific industrial needs.

We start by knowing your problem or your requirement (under confidentiality agreement) and then we propose you a viable solution and a budget for implementation. We not only develop a solution for you but we adapt manufacturing facilities, budget and product prices to your specific needs.

Our turnaround time between problem specification and implementation of the solution in your process line is tipically less than 9 months, even for the most complicated problems.

Please contact us with your specific requirement and our technical team will be pleased to get hands on!

What we do best

Why us?